This content is from: Home

Biotech tax break is latest plan to revive US pharma

A Bill with versions in the US Senate and House of Representatives provides tax breaks for life sciences research and investment in the hope of creating jobs, despite criticism that similar efforts have backfired in the past.

To access our market-driven intelligence please request a trial here.

Read this article – and more – for a one-week period.


Are you already an ITR subscriber? Log in here

Instant access to all of our content. Membership Options | One Week Trial